Chapter 11 The European Union in Panglossian Stagnation

Abstract This chapter provides a critical exploration of the European Union’s impact on the 2016 United Nations General Assembly Special Session (UNGASS) proceedings and Outcome document. It demonstrates that the ability to produce a European ‘common position’ ahead of the UNGASS debates represents a significant step forward in the ability to ‘speak with one voice’ in the global illicit drug policy arena, and has played an important role in ensuring key issues such as human rights and public health remain on the agenda. In highlights, however, a European failure to engage with issues such as the continuing suitability of the international drug conventions to preside over the current climate of drug policy innovation and experimentation, and the unintended consequences of a ‘war on drugs’ approach. Ultimately, therefore, it argues that these failures will hamper the development of a more progressive and effective global drug policy.

[1]  D. Bewley-Taylor.  Towards revision of the UN drug control conventions: harnessing like-mindedness. , 2013, The International journal on drug policy.

[2]  R. Room.  Reform by subtraction: the path of denunciation of international drug treaties and reaccession with reservations. , 2012, The International journal on drug policy.

[3]  P. Reuter,et al.  How well do international drug conventions protect public health? , 2012, The Lancet.

[4]  Coletta A. Youngers.  The Obama Administration’s Drug Control Policy on Auto-Pilot , 2011 .

[5]  Caroline Chatwin.  Drug Policy Harmonization and the European Union , 2011 .

[6]  A. Ritter.  How do drug policy makers access research evidence? , 2009, The International journal on drug policy.

[7]  Damon Barrett.  Recalibrating the Regime: The Need for a Human Rights Based Approach to International Drug Policy , 2008 .

[8]  P. O'Hare.  Merseyside, the first harm reduction conferences, and the early history of harm reduction. , 2007, The International journal on drug policy.

[9]  G. Mulgan.  Government, knowledge and the business of policy making: the potential and limits of evidence-based policy , 2005 .

[10]  Caroline Chatwin.  Drug Policy Developments within the European Union. The Destabilizing Effects of Dutch and Swedish Drug Policies , 2003 .

[11]  Tim Boekhout van Solinge.  Dutch Drug Policy in a European Context , 1999 .

[12]  T. B. V. Solinge.  Dutch Drug Policy in a European Context , 1999 .

[13]  S. Lenton,et al.  The definition of harm reduction. , 1998, Drug and alcohol review.

[14]  G A Marlatt,et al.  Harm reduction: come as you are. , 1996, Addictive behaviors.